Transgene Biotek Limited (TRABI.BO)
INR 7.34
(-0.53%)
INR 7.34
(-0.53%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.47 Million | 2305.00 | 978.02 Thousand | 125.68 Thousand | 1.39 Million | -17.38 Million |
| Net Income | -6.55 Million | -60.08 Million | -104.02 Million | -104.34 Million | -109.62 Million | -87.92 Million |
| Depreciation & Amortization | 923 Thousand | 49.5 Million | 99.24 Million | 99.08 Million | 98.96 Million | 98.94 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.38 Million | 10.52 Million | 5.24 Million | 4.48 Million | 9.99 Million | -11.44 Million |
| Other non-cash items | 1.64 Million | 59.75 Thousand | 513.92 Thousand | 908.84 Thousand | 2.05 Million | -16.95 Million |
| Investing Cash Flow | - | -123.01 Thousand | -968.54 Thousand | -273.85 Thousand | - | 17.35 Million |
| Investments in PPE | - | -14.66 Thousand | -18.39 Thousand | -273.85 Thousand | - | -759.62 Thousand |
| Acquisitions | - | - | -950.15 Thousand | - | - | 18.11 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -108.35 Thousand | -18.39 Thousand | - | - | 18.11 Million |
| Financing Cash Flow | 7.52 Million | 8.51 Million | 4.58 Million | 10.00 | -2 Million | -9.67 Million |
| Debt repayment | -7.52 Million | -8.51 Million | -4.58 Million | -7.36 Million | -2 Million | -9.67 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 10.00 | - | - |
| Other Financing Activities | - | 17.02 Million | 9.17 Million | 7.36 Million | -2 Million | 5.00 |
| Accounts receivables | - | 8.5 Million | 4.58 Million | 7.36 Million | 10.14 Million | -9.67 Million |
| Accounts payables | -256 Thousand | 258.94 Thousand | -368.09 Thousand | -1.4 Million | 890.73 Thousand | -2.58 Million |
| Inventory | -1000.00 | 608.61 Thousand | -741.12 Thousand | 179.21 Thousand | -73.4 Thousand | 110 Thousand |
| Other working capital | -1.12 Million | 1.14 Million | 1.76 Million | -1.66 Million | -964.2 Thousand | 713.93 Thousand |
| Cash at beginning of period | 30.52 Thousand | 151.22 Thousand | 141.74 Thousand | 389.9 Thousand | 996.3 Thousand | 1.01 Million |
| Cash at end of period | 77 Thousand | 30.52 Thousand | 151.22 Thousand | 241.74 Thousand | 389.9 Thousand | 996.3 Thousand |
| Capital Expenditure | - | -14.66 Thousand | -18.39 Thousand | -273.85 Thousand | - | -759.62 Thousand |
| Effect of forex changes on cash | - | -8.51 Million | -4.58 Million | - | - | 9.67 Million |
| Net cash flow / Change in cash | 46.47 Thousand | -120.7 Thousand | 9485.00 | -148.16 Thousand | -606.39 Thousand | -23.02 Thousand |
| Free Cash Flow | -7.47 Million | -12.35 Thousand | 959.63 Thousand | -148.17 Thousand | 1.39 Million | -18.14 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.55 Million | -2.72 Million | -1.19 Million | -1.32 Million | -1.38 Million | -60.08 Million |
| Depreciation & Amortization | 923 Thousand | - | 231 Thousand | 230.84 Thousand | 230.84 Thousand | 49.5 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.38 Million | - | - | - | - | 10.52 Million |
| Other non-cash items | 1.64 Million | 2.72 Million | 1.19 Million | 1.32 Million | 1.38 Million | 59.75 Thousand |
| Investing Cash Flow | - | - | - | - | - | -123.01 Thousand |
| Investments in PPE | - | - | - | - | - | -14.66 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | -108.35 Thousand |
| Financing Cash Flow | 7.52 Million | - | - | - | - | 8.51 Million |
| Debt repayment | -7.52 Million | - | - | - | - | -8.51 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | 17.02 Million |
| Accounts receivables | - | - | - | - | - | 8.5 Million |
| Accounts payables | -256 Thousand | - | - | - | - | 258.94 Thousand |
| Inventory | -1000.00 | - | - | - | - | 608.61 Thousand |
| Other working capital | -1.12 Million | - | - | - | - | 1.14 Million |
| Cash at beginning of period | 30.52 Thousand | - | 105.08 Thousand | 1.43 Million | 30.52 Thousand | 151.22 Thousand |
| Cash at end of period | 77 Thousand | - | 567.08 Thousand | 105.08 Thousand | -1.38 Million | 30.52 Thousand |
| Capital Expenditure | - | - | - | - | - | -14.66 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | -8.51 Million |
| Net cash flow / Change in cash | 46.47 Thousand | - | 462 Thousand | -1.32 Million | -1.41 Million | -120.7 Thousand |
| Free Cash Flow | -7.47 Million | - | 462 Thousand | -1.32 Million | -1.38 Million | -12.35 Thousand |
SHYAMTEL
FMOCF
KIMS
TBR
JSE
NICL